
The company states: “Bayer (BAYRY) announced that the U.S. Food and Drug Administration has approved SUNHARBO(R) (asundexian), 50 mg tablets, a first-in-class, once daily, Factor XIa inhibitor indicated in combination
Compare up to 40 stocks
Compared Stocks: 1 / 40
| Ticker | Company Name | Price | Change | % Change | |
|---|---|---|---|---|---|
| BAYZF | Bayer | 63.00 | 29.95 | 90.63% |
| Name | Price | % Change | |
|---|---|---|---|
| $63.00 | +90.63% |

The company states: “Bayer (BAYRY) announced that the U.S. Food and Drug Administration has approved SUNHARBO(R) (asundexian), 50 mg tablets, a first-in-class, once daily, Factor XIa inhibitor indicated in combination

Group sales came in at EUR 10.05B vs. EUR 9.66B last year. EBITDA before special items was EUR 1.62B vs. EUR 1.5B last year. Net income amounted to (EUR 672M)

Bayer (BAYRY) is operationally on track to deliver its full-year commitments at the nine-month mark, while also aiming to capitalize on improved trends as the year draws to a close.

“Our year-to-date performance is a proof point that our strategy is working, and it gives us the confidence to improve our targets for the year on adjusted EBITDA, cash and

Bayer Ag (UK) (0P6S) is scheduled to report 3rd quarter earnings on 11/03/2026, before the market opens. Regarding Q3 estimates, Wall Street analysts expect Bayer Ag (UK) to post earnings

New late-breaking data to be presented by the Australian and New Zealand Urogenital and Prostate, ANZUP, Clinical Trials Group at the European Society for Medical Oncology, ESMO, Congress 2026 will

Bayer (BAYRY) announced a partnership with actress and menopause advocate Melissa Joan Hart to increase awareness about Lynkuet 60mg capsules, Bayer’s FDA-approved, hormone-free prescription treatment for moderate to severe hot

Bayer (BAYRY) announced that the FDA accepted the company’s supplemental new drug application, or sNDA, for Kerendia, which is being investigated for the treatment of adults with chronic kidney disease,

Bayer (BAYRY) announced plans to invest $2.2B in a new pharmaceutical manufacturing site in New Albany, Ohio, U.S. Building on more than $7B in U.S. pharma R&D and manufacturing spend

lka-Seltzer Plus will relaunch in 2026 as Alka-Seltzer Cold, introducing a more intuitive brand architecture, simplified packaging and value-focused options designed to make the cough/cold aisle easier to shop. The
| Name | Analyst | Analyst Firm | Rating | Analyst Price Target | Action | Date |
|---|---|---|---|---|---|---|
| buy | Reiterated | Nov 10, 2026 | ||||
| hold | Reiterated | Nov 10, 2026 | ||||
| buy | Reiterated | Nov 5, 2026 | ||||
| buy | Reiterated | Nov 4, 2026 | ||||
| buy | Reiterated | Nov 4, 2026 | ||||
| buy | Reiterated | Nov 3, 2026 | ||||
| buy | Reiterated | Sep 10, 2026 | ||||
| buy | Reiterated | Sep 8, 2026 | ||||
| hold | Assigned | Jul 7, 2026 | ||||
| buy | Upgraded | Apr 29, 2026 |
| Name | Upcoming Earnings Date | Market Cap | EPS Forecast | Sales Forecast | PEG Ratio | P/E Ratio |
|---|---|---|---|---|---|---|
| Feb 24, 2027TBA | $61.20B | $0.66 | $13.01B | -0.24 | -38.45 |
Compare Stocks Side-by-Side
Our stock comparison tool allows investors to compare multiple stocks simultaneously, providing comprehensive insights into key metrics, financial data, and analyst ratings. Make informed investment decisions by analyzing stocks side by side.
Key Features of Our Stock Comparison
How to Use the Stock Comparison Tool
Simply enter the ticker symbols of the stocks you want to compare in the search box above. You can add up to 40 stocks at once. The tool will automatically populate comparison tables with the latest data, allowing you to analyze and contrast different investment opportunities across various sectors and industries.
Popular Stock Comparisons
Investors frequently compare stocks within the same sector to identify the best investment opportunities. Popular comparisons include tech giants like Apple (AAPL) vs. Microsoft (MSFT), semiconductor leaders Nvidia (NVDA) vs. AMD, beverage companies Coca-Cola (KO) vs. Pepsi (PEP), and electric vehicle makers Tesla (TSLA) vs. Rivian (RIVN).
Why Compare Stocks?
Comparing stocks helps investors identify which companies offer the best value, growth potential, and risk-adjusted returns. By analyzing multiple stocks side by side, you can better understand relative valuations, competitive advantages, and market positioning before making investment decisions.